Here are Top Health Stories of the day
Help Expedite NEET PG Counselling: Doctors tell Chief Justice of India
Pointing towards the unusual delay in the Post-graduate medical admission this year, the Federation of Resident Doctors' Association (FORDA) India has recently written to the Chief Justice of the Supreme Court requesting him to expedite the counselling process.
Submitting that an entire academic year of the upcoming P.G Resident Doctors is on the verge of getting wasted, owing to multiple delays in conduction of the whole process, FORDA has mentioned in the letter, "We would hereby like to request you to kindly take note of the plight of Resident Doctors as well as P.G Aspirants & take necessary measures for expediting the hearing in the pending case followed by directions for expediting the process of NEET-PG 2021 Counselling."
For more details, check out the full story on the link below:
Help Expedite NEET PG Counselling: Doctors Tell Chief Justice Of India
2. Covishield re-vaccination after Covaxin: SC saids to wait for WHO decision
The Supreme Court on Friday said it will wait for the WHO's decision on indigenous vaccine Covaxin's recognition, before taking up a plea seeking permission for voluntary re-vaccination with Covishield, for those fully vaccinated with Covaxin, so as to enable them to travel abroad.
A bench headed by Justice D.Y. Chandrachud observed that it has been reported that Bharat Biotech, manufacturer of Covaxin, has submitted the latest data to the WHO. The bench added that the decision is expected to come and told the petitioner's counsel to wait for some time, as there will not be any difficulty when the WHO recognises Covaxin.
For more details, check out the full story on the link below:
Covishield Re-Vaccination After Covaxin: SC Saids To Wait For WHO Decision
2 Chattisgarh Medical Colleges lose NMC permission, 1 gets nod for 100 MBBS seats
Bringing good news to the medical aspirants in Chhattisgarh, the Medical Assessment and Rating Board (MARB), operative under the National Medical Commission (NMC) has approved the Kanker Government Medical College to admit 100 students in the MBBS course.
Even though permission was sought for 150 MBBS seats, MARB in a letter directed to the Dean of the institute granted permission for 100 MBBS seats and clarified that the dean should provide all infrastructural facilities in terms of teaching and non-teaching staff, building, equipment and hospital facilities as per NMC norms. Further, the letter clearly mentioned that the college shouldn't commence admission till the time it gets a formal permission from the MARB.
For more details, check out the full story on the link below:
2 Chattisgarh Medical Colleges Lose NMC Permission, 1 Gets Nod For 100 MBBS Seats
FDA okays emergency Authorization of Pfizer COVID-19 Vaccine for kids between 5 to 11 Years
The U.S. Food and Drug Administration has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA's thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.
For more details, check out the full story on the link below:
FDA Okays Emergency Authorization Of Pfizer COVID-19 Vaccine For Kids Between 5 To 11 Years
NBE sanctions 2 seats for DrNB Clinical Immunology and Rheumatology at Odisha Medical College
The Srirama Chandra Bhanja Medical College & Hospital (SCB Medical College) is all set to begin a doctorate degree in Immunology, this academic session onwards.
According to a recent report by New Indian Express, the National Board of Examination (NBE) has sanctioned two seats to offer a three-year Doctorate of National Board (DrNB) degree course on Clinical Immunology and Rheumatology from the current academic session.
For more details, check out the full story on the link below:
NBE Sanctions 2 Seats For DrNB Clinical Immunology And Rheumatology At Odisha Medical College
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.